Shares of Reckitt Benckiser Group plc (LON:RB) have received a consensus rating of “Strong Buy” from the twelve ratings firms that are currently covering the stock, Marketbeat reports. One equities research analyst has rated the stock with a buy rating and one has assigned a strong buy rating to the company. The average 1-year price objective among brokers that have updated their coverage on the stock in the last year is GBX 7,270 ($94.98).
RB has been the topic of several research analyst reports. Berenberg Bank set a GBX 7,870 ($102.82) price objective on shares of Reckitt Benckiser Group in a report on Wednesday, July 28th. Sanford C. Bernstein set a GBX 5,400 ($70.55) target price on shares of Reckitt Benckiser Group in a research report on Monday, August 2nd. JPMorgan Chase & Co. set a GBX 8,500 ($111.05) target price on shares of Reckitt Benckiser Group in a research report on Thursday, September 2nd. Deutsche Bank Aktiengesellschaft set a GBX 7,200 ($94.07) target price on Reckitt Benckiser Group in a research note on Thursday, July 29th. Finally, Jefferies Financial Group set a GBX 5,700 ($74.47) target price on Reckitt Benckiser Group in a research note on Thursday, September 2nd.
The firm has a market cap of £48.36 billion and a price-to-earnings ratio of 40.79. The company has a debt-to-equity ratio of 116.01, a quick ratio of 0.53 and a current ratio of 0.77. The business’s 50-day moving average is GBX 6,356.14. Reckitt Benckiser Group has a 1 year low of GBX 5,782 ($75.54) and a 1 year high of GBX 8,020 ($104.78).
Reckitt Benckiser Group plc manufactures, markets, and sells health, hygiene, and home products. The company offers acne treatment creams, facial washes, and cleansing pads; disinfection, hygiene, and first aid products; condoms, sex toys, and lubricants; heartburn and indigestion solutions; and cough and chest congestion, multi-symptom, and sinus remedies for adults and children under the Clearasil, Dettol, Durex, Gaviscon, and Mucinex brands.
See Also: Most Volatile Stocks
Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.